Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-05-18 @ 1:31 PM
Study NCT ID:
NCT01295593
Status:
UNKNOWN
Last Update Posted:
2012-06-07
First Post:
2011-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VPA-CdA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None